Swallowing the FDA Red Pill
Washington Examiner | Sally C. Pipes
November 29, 2021
Earlier this month, the Biden administration bought 10 million courses of Pfizer’s new COVID-19 pill, Paxlovid. Thanks to the Food and Drug Administration, however, it may be months before anyone can take it, as the agency hasn’t yet offered up a timetable for approving it. Its inaction will almost certainly result in scores of preventable deaths.
Read more. . . |
|
Charging the Unvaccinated More for Health Care is a Slippery Slope
Orlando Sentinel | Sally C. Pipes
November 29, 2021
This month, Delta Airlines began levying a $200 monthly surcharge on unvaccinated employees enrolled in the company’s health plan for the financial “risk” they are supposedly imposing on the company . . . In other words, medical underwriting — the practice of setting insurance premiums in line with actuarial risk — is making a bit of a comeback. This time, it has the staunch support of many Democratic partisans.
Read more. . . |
|
Democrats' Creative Accounting Can't Hide Build Back Better's True Cost
Newsmax | Sally C. Pipes
November 24, 2021
For weeks, President Joe Biden has insisted that the Democrats’ ‘Build Back Better’ spending bill would be “fully paid for.” The Congressional Budget Office begs to differ. In its newly released analysis of the bill, the CBO projects that ‘Build Back Better’ will increase the deficit by $367 billion over the next decade. |
|
The FDA's Dysfunction is a Public Health Crisis of its Own
Forbes.com | Sally C. Pipes
November 23, 2021
. . . In my last column, I detailed how the FDA’s failures reviewing and approving tests for COVID-19 have prolonged the pandemic. This week, we have a new source of dysfunction to explore—the FDA’s foot-dragging on antiviral pills that treat COVID-19 and booster shots. Americans are needlessly suffering—and dying—because of that dysfunction. |
|
|
|
